| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 7 |
| 1 | ATEZOLIZUMAB | 6 |
| 2 | BEVACIZUMAB | 6 |
| 3 | CARBOPLATIN | 6 |
| 4 | METHOTREXATE | 6 |
| 5 | OSIMERTINIB | 6 |
| 6 | PEMETREXED | 6 |
| 7 | PEMETREXED DISODIUM | 6 |
| 8 | ADALIMUMAB | 2 |
| 9 | PREDNISONE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | OXYMETAZOLINE HYDROCHLORIDE | 1 | 0.0002 |
| 1 | OSIMERTINIB | 6 | 0.0002 |
| 2 | TEPROTUMUMAB | 1 | 0.0002 |
| 3 | PEMETREXED DISODIUM | 6 | 0.0002 |
| 4 | CILTACABTAGENE AUTOLEUCEL | 1 | 0.0002 |
| 5 | ATEZOLIZUMAB | 6 | 0.0002 |
| 6 | EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR DISOPROXIL FUMARATE | 1 | 0.0001 |
| 7 | OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN | 1 | 0.0001 |
| 8 | BOTULINUM TOXIN TYPE A | 1 | 0.0001 |
| 9 | BEVACIZUMAB | 6 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 1 | 0.0002 |
| 1 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 6 | 0.0001 |
| 2 | Androgen [EPC] | 1 | 0.0000 |
| 3 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 4 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 6 | 0.0000 |
| 5 | Soluble Guanylate Cyclase Stimulator [EPC] | 1 | 0.0000 |
| 6 | Platinum-based Drug [EPC] | 6 | 0.0000 |
| 7 | beta3-Adrenergic Agonist [EPC] | 1 | 0.0000 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 7 | 0.0000 |
| 9 | Cardiac Glycoside [EPC] | 1 | 0.0000 |